Home › Graft-Versus-Host Disease › Pennsylvania › Pittsburgh
Graft-Versus-Host Disease clinical trials in Pittsburgh, PA
4 studies for Graft-Versus-Host Disease are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
RecruitingPhase 1
- UMPC Hillman Cancer Center, Pittsburgh
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
RecruitingPhase 2
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
RecruitingPhase 2
- University of Pittsburgh Medical Center (Data Collection Only), Pittsburgh
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- UPMC Hillman Cancer Center, Pittsburgh
Graft-Versus-Host Disease trials in other cities
- Boston, MA10 studies
- New York City, NY7 studies
- Columbus, OH6 studies
- Atlanta, GA5 studies
- Washington, DC5 studies
- Portland, OR4 studies
- Baldwin Park, CA4 studies
- Tampa, FL4 studies
- St. Louis, MO4 studies
- Detroit, MI4 studies
- Miami, FL4 studies
- Queens, NY4 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)41 studies
- Breast Cancer39 studies
- Colorectal Cancer32 studies
- Metastatic Cancer31 studies
- Melanoma31 studies
- Ovarian Cancer30 studies
- Endometrial Cancer23 studies
- Lung Cancer23 studies
- Prostate Cancer23 studies
- Stroke22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.